Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BU5N
|
|||
| Former ID |
DNC013359
|
|||
| Drug Name |
3-chloro-5-(2-methylquinolin-7-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL396135; 3-chloro-5-(2-methylquinolin-7-yl)benzonitrile; SCHEMBL4297824
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H11ClN2
|
|||
| Canonical SMILES |
CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)Cl
|
|||
| InChI |
1S/C17H11ClN2/c1-11-2-3-13-4-5-14(9-17(13)20-11)15-6-12(10-19)7-16(18)8-15/h2-9H,1H3
|
|||
| InChIKey |
NJKOTXYVFGIDOL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4415-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.